1. Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cells
    Halina Was et al, 2019, Clinical Epigenetics CrossRef
  2. Effect of valproic acid on overall survival in patients with high-grade gliomas undergoing temozolomide
    Yu-Jen Kuo et al, 2020, Medicine CrossRef
  3. Valproic Acid: A Promising Therapeutic Agent in Glioma Treatment
    Wei Han et al, 2021, Frontiers in Oncology CrossRef
  4. Alteration of intracellular metabolome in osteosarcoma stem cells revealed by liquid chromatography-tandem mass spectrometry
    Zhihui Zhong et al, 2019, Talanta CrossRef
  5. The Epigenetics of Glioma Stem Cells: A Brief Overview
    Luis M. Valor et al, 2020, Frontiers in Oncology CrossRef
  6. Diazepam diminishes temozolomide efficacy in the treatment of U87 glioblastoma cell line
    Jovana Drljača et al, 2022, CNS Neuroscience & Therapeutics CrossRef
  7. Under explored epigenetic modulators: role in glioma chemotherapy
    Yan-Hong Chen et al, 2018, European Journal of Pharmacology CrossRef
  8. Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation
    Gabriele Riva et al, 2018, Genes CrossRef
  9. Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?
    Chiara Cilibrasi et al, 2016, PPAR Research CrossRef
  10. Advances in histone deacetylase inhibitors in targeting glioblastoma stem cells
    R. Gajendra Reddy et al, 2020, Cancer Chemotherapy and Pharmacology CrossRef
  11. Emerging therapeutic potential of anti-psychotic drugs in the management of human glioma: A comprehensive review
    Muhamad N.A. Kamarudin et al, 2019, Oncotarget CrossRef
  12. Molecular Pathways and Genomic Landscape of Glioblastoma Stem Cells: Opportunities for Targeted Therapy
    Andrew M. Hersh et al, 2022, Cancers CrossRef
  13. Cross-reactivity between histone demethylase inhibitor valproic acid and DNA methylation in glioblastoma cell lines
    Anna-Maria Barciszewska et al, 2022, Frontiers in Oncology CrossRef
  14. Molecular imaging HDACs class IIa expression-activity and pharmacologic inhibition in intracerebral glioma models in rats using PET/CT/(MRI) with [18F]TFAHA
    Maxwell T. Laws et al, 2019, Scientific Reports CrossRef
  15. Translational gap in ongoing clinical trials for glioma
    Alecia Florence Guishard et al, 2018, Journal of Clinical Neuroscience CrossRef